BRANDOLINO, FABIO
BRANDOLINO, FABIO
DIPARTIMENTO DI MEDICINA INTERNA E TERAPIA MEDICA
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis
2020-01-01 Monti, S.; Delvino, P.; Bellis, E.; Milanesi, A.; Brandolino, F.; Montecucco, C.
Novel Therapies for ANCA-associated Vasculitis
2021-01-01 Monti, Sara; Brandolino, Fabio; Milanesi, Alessandra; Xoxi, Blerina; Delvino, Paolo; Montecucco, Carlomaurizio
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
2023-01-01 De Stefano, Ludovico; Balduzzi, Silvia; Bogliolo, Laura; D'Onofrio, Bernardo; di Lernia, Michele; Mauric, Eleonora; Milanesi, Alessandra; Brandolino, Fabio; Rocca, Clarissa; Chiricolo, Sofia; Manzo, Antonio; Montecucco, Carlomaurizio; Bugatti, Serena
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore)
2020-01-01 Colaneri, M.; Bogliolo, L.; Valsecchi, P.; Sacchi, P.; Zuccaro, V.; Brandolino, F.; Montecucco, C.; Mojoli, F.; Giusti, E. M.; Bruno, R.
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis
2021-01-01 Ponte, Cristina; Monti, Sara; Scirè, Carlo Alberto; Delvino, Paolo; Khmelinskii, Nikita; Milanesi, Alessandra; Teixeira, Vítor; Brandolino, Fabio; Saraiva, Fernando; Montecucco, Carlomaurizio; Fonseca, João Eurico; Schmidt, Wolfgang A; Luqmani, Raashid Ahmed
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis | 1-gen-2020 | Monti, S.; Delvino, P.; Bellis, E.; Milanesi, A.; Brandolino, F.; Montecucco, C. | |
| Novel Therapies for ANCA-associated Vasculitis | 1-gen-2021 | Monti, Sara; Brandolino, Fabio; Milanesi, Alessandra; Xoxi, Blerina; Delvino, Paolo; Montecucco, Carlomaurizio | |
| Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs | 1-gen-2023 | De Stefano, Ludovico; Balduzzi, Silvia; Bogliolo, Laura; D'Onofrio, Bernardo; di Lernia, Michele; Mauric, Eleonora; Milanesi, Alessandra; Brandolino, Fabio; Rocca, Clarissa; Chiricolo, Sofia; Manzo, Antonio; Montecucco, Carlomaurizio; Bugatti, Serena | |
| Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) | 1-gen-2020 | Colaneri, M.; Bogliolo, L.; Valsecchi, P.; Sacchi, P.; Zuccaro, V.; Brandolino, F.; Montecucco, C.; Mojoli, F.; Giusti, E. M.; Bruno, R. | |
| Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis | 1-gen-2021 | Ponte, Cristina; Monti, Sara; Scirè, Carlo Alberto; Delvino, Paolo; Khmelinskii, Nikita; Milanesi, Alessandra; Teixeira, Vítor; Brandolino, Fabio; Saraiva, Fernando; Montecucco, Carlomaurizio; Fonseca, João Eurico; Schmidt, Wolfgang A; Luqmani, Raashid Ahmed |